These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1514766)

  • 21. [HVB and HVC infections in nephrology].
    Pol S
    Nephrologie; 2001; 22(6):321-2. PubMed ID: 11715611
    [No Abstract]   [Full Text] [Related]  

  • 22. The liver. Part 6: Liver transplantation.
    Day HL; Taylor RM
    Nurs Times; 2006 Jan 17-23; 102(3):30-2. PubMed ID: 16440973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in prevalence of viral infections in Australian musculoskeletal tissue donors and projections of incidence and residual risk, 1993-2004.
    Yao F; Seed C; Kiely P; Parker S; Qian Y; Farrugia A; Morgan D; Wood D; Zheng MH
    Transplantation; 2008 Sep; 86(5):746-8. PubMed ID: 18791459
    [No Abstract]   [Full Text] [Related]  

  • 24. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation.
    Marubashi S; Dono K; Asaoka T; Hama N; Gotoh K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
    Transplant Proc; 2006 Jun; 38(5):1407-10. PubMed ID: 16797318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic cholestasis after liver transplantation.
    Corbani A; Burroughs AK
    Clin Liver Dis; 2008 Feb; 12(1):111-29, ix. PubMed ID: 18242500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute renal failure after liver transplantation: incidence, etiology, therapy, and outcome.
    Junge G; Schewior LV; Kohler S; Neuhaus R; Langrehr JM; Tullius S; Kahl A; Frei U; Neuhaus P
    Transplant Proc; 2006 Apr; 38(3):723-4. PubMed ID: 16647455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of posttransplantation viral hepatitis C.
    Shiffman ML
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S79-86. PubMed ID: 9742498
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Viral hepatitis and liver transplantation].
    Samuel D; Féray C; Bismuth H
    Rev Prat; 1995 Jan; 45(2):197-201. PubMed ID: 7725022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
    Marcellin P; Samuel D; Areias J; Loriot MA; Arulnaden JL; Gigou M; David MF; Bismuth A; Reynes M; Bréchot C
    Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of hepatitis serology on development of leukopenia after solid organ transplantation.
    Karakus S; Arin BE; Arat Z; Karakayali H; Haberal M
    Transplant Proc; 2008; 40(1):199-201. PubMed ID: 18261586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of liver transplantation in patients with hepatitis B infection.
    Holt CD; Millis JM; Busuttil RW
    Clin Transplant; 1995 Jun; 9(3 Pt 2):269-76. PubMed ID: 7670175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Can the risk of recurrence of the initial disease after liver transplantation be evaluated?].
    Doffoel M; Vetter D; Wolf P
    Gastroenterol Clin Biol; 1989 Dec; 13(12):963-6. PubMed ID: 2696662
    [No Abstract]   [Full Text] [Related]  

  • 38. De novo hepatitis B virus infection after orthotopic liver transplantation.
    Liu PP; Chen CL; Chen YS; Tai DI
    Transplant Proc; 1996 Jun; 28(3):1684-6. PubMed ID: 8658839
    [No Abstract]   [Full Text] [Related]  

  • 39. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M; Neuberger JM; Gunson BK; Hübscher SG
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent hepatitis B infection in hepatic allograft.
    Rakela J
    Mayo Clin Proc; 1989 May; 64(5):597. PubMed ID: 2657242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.